Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future Perspectives | Zendy

Karla N. Samman | Zendy; Carolyn Ross | Zendy; Christian Pagnoux | Zendy; JeanPaul Makhzoum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future Perspectives

Author(s) -

Karla N. Samman,

Carolyn Ross,

Christian Pagnoux,

JeanPaul Makhzoum

Publication year - 2021

Publication title -

international journal of rheumatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.8

H-Index - 33

eISSN - 1687-9279

pISSN - 1687-9260

DOI - 10.1155/2021/5534851

Subject(s) - microscopic polyangiitis , anca associated vasculitis , granulomatosis with polyangiitis , medicine , limiting , vasculitis , intensive care medicine , pathology , disease , engineering , mechanical engineering

Significant progress has been made in the treatment of ANCA-associated vasculitides (AAV), notably in granulomatosis with polyangiitis and microscopic polyangiitis. Over the past few years, many innovative studies have changed the way we now induce and maintain remission in AAV; achieving remission while limiting treatment toxicity is the key. This article provides an in-depth, up-to-date summary of recent trials and suggests treatment algorithms for induction and maintenance of remission based on the latest guidelines. Future possible therapies in AAV will also be discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research